1. Home
  2. BNZI vs CDIO Comparison

BNZI vs CDIO Comparison

Compare BNZI & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Banzai International Inc.

BNZI

Banzai International Inc.

HOLD

Current Price

$3.49

Market Cap

5.7M

Sector

N/A

ML Signal

HOLD

Logo Cardio Diagnostics Holdings Inc.

CDIO

Cardio Diagnostics Holdings Inc.

HOLD

Current Price

$2.17

Market Cap

4.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNZI
CDIO
Founded
2016
2017
Country
United States
United States
Employees
34
17
Industry
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.7M
4.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BNZI
CDIO
Price
$3.49
$2.17
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$24.00
N/A
AVG Volume (30 Days)
1.7M
73.3K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$41.28
$171,906.75
Revenue Next Year
$0.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.97
52 Week High
$8.10
$7.91

Technical Indicators

Market Signals
Indicator
BNZI
CDIO
Relative Strength Index (RSI) 52.00 63.65
Support Level $0.84 $1.68
Resistance Level $3.51 $2.35
Average True Range (ATR) 1.06 0.18
MACD -0.22 0.07
Stochastic Oscillator 5.56 95.21

Price Performance

Historical Comparison
BNZI
CDIO

About BNZI Banzai International Inc.

Banzai International Inc is a Software as a Service (SaaS) company operating in the marketing technology (MarTech) industry. The group provides customers with tools to help them market and sell with greater efficiency and impact. Its customers include Amazon, Dell, Salesforce, Aflac, Thermo Fisher Scientific, RBC Wealth Management, Fitch Group, and many other brands. The Company has three reportable operating segments: Banzai Operating Co, Inc., OpenReel, and Vidello. Its segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions, including video production and editing, for businesses of all sizes. Geographically, it operates in the Americas, Europe, the Middle East and Africa (EMEA), and the Asia Pacific.

About CDIO Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

Share on Social Networks: